Imerys Talc is in a long-running Delaware chapter 11 posture centered on implementing a talc-liability channeling resolution, with the current docket showing plan, insurance, future-claimant and professional-compensation work rather than an operating-company liquidity crisis. The case began on February 13, 2019, when Imerys Talc America, Imerys Talc Vermont and Imerys Talc Canada filed chapter 11 after roughly 14,650 talc-related claims, including approximately 13,800 ovarian-cancer claims and 850 mesothelioma claims, had made the tort docket the central restructuring problem despite the debtors’ continuing talc operations and asserted insurance resources; the first-day declaration framed the objective as a consensual plan that would channel present and future talc claims to a trust while preserving going-concern value through ordinary-course operating relief, insurance preservation and critical-vendor authority in the Picard First Day DeclarationDkt. 10.
The case path has been shaped less by funded-debt leverage than by mass-tort allocation, insurance recovery and third-party litigation. Early and subsequent adversary proceedings show the debtors and related parties using the bankruptcy court to address stay, indemnity, declaratory-judgment and talc-liability issues involving Cyprus entities, Johnson & Johnson parties and talc claimants, including the debtors’ 2019 injunctive and declaratory action against Cyprus parties in the Cyprus Adversary ComplaintDkt. 1, Cyprus’s 2020 declaratory action against the debtors and J&J parties in the Cyprus Declaratory ComplaintDkt. 1, and the debtors’ 2021 complaint against Johnson & Johnson and Johnson & Johnson Consumer in the . The restructuring expanded in March 2025 when Imerys Talc Italy filed chapter 11 to join the North American cases under a global settlement and prepackaged second joint plan supported by talc personal-injury claimants, using sections 524(g) and 105(a) to channel talc liabilities to a Talc Personal Injury Trust while leaving non-talc claims unimpaired, as described in the .
The live case now appears to be in execution and claims-resolution mode, with recent filings focused on fee processes, ordinary-course professional costs, insurance-coverage work, plan cooperation issues and representation of future claimants. May 2026 activity included Young Conaway’s continued-disinterestedness disclosure for its FCR representation in the Twenty-Second Supplemental Harron DeclarationDkt. 8299, the debtors’ twenty-ninth quarterly ordinary-course professional fee statement for February through April 2026 in the OCP Fee StatementDkt. 8305, and Gilbert LLP’s April 2026 fee application for special insurance counsel work that included insurance analysis, settlement proposals, Cyprus claims, missing-policy issues and plan-related cooperation questions in the Gilbert Monthly Fee ApplicationDkt. 8306. The near-term calendar is administrative: objections to the FCR/Young Conaway April fee application are due June 16, 2026, objections to Gilbert’s application are due June 17, 2026, and the next scheduled hearing is a June 18, 2026 claims-and-administration fee-application hearing.
